"Macular Edema" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)
| Descriptor ID |
D008269
|
| MeSH Number(s) |
C11.768.585.439.245
|
| Concept/Terms |
Irvine-Gass Syndrome- Irvine-Gass Syndrome
- Irvine Gass Syndrome
- Syndrome, Irvine-Gass
- Cystoid Macular Edema, Postoperative
Macular Edema, Cystoid- Macular Edema, Cystoid
- Edema, Cystoid Macular
- Cystoid Macular Dystrophy
- Macular Dystrophy, Dominant Cystoid
- Central Retinal Edema, Cystoid
- Cystoid Macular Edema
|
Below are MeSH descriptors whose meaning is more general than "Macular Edema".
Below are MeSH descriptors whose meaning is more specific than "Macular Edema".
This graph shows the total number of publications written about "Macular Edema" by people in this website by year, and whether "Macular Edema" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Macular Edema" by people in Profiles.
-
The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study. Ophthalmic Surg Lasers Imaging Retina. 2022 10; 53(10):553-560.
-
Safety and Outcomes of Intravitreal Aflibercept in Diabetic Macular Edema - A Systematic Review. Curr Pharm Des. 2022; 28(21):1758-1768.
-
Intravitreal injections of anti-VEGF agents during COVID-19 pandemic: clinical audit from Tanta University Hospital. Int Ophthalmol. 2021 Apr; 41(4):1437-1443.
-
PARAFOVEAL MICROVASCULAR FEATURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN EYES WITH CIRCUMSCRIBED CHOROIDAL HEMANGIOMA. Retina. 2018 Jun; 38(6):1091-1099.
-
Markers of poor glycemic control are helpful to assess the risk of pseudophakic macular edema in diabetic cataract surgery patients. J Cataract Refract Surg. 2018 03; 44(3):415.
-
Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. BMC Ophthalmol. 2017 Feb 20; 17(1):16.
-
Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats. Invest Ophthalmol Vis Sci. 2016 05 01; 57(6):2706-13.
-
Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure. Exp Eye Res. 2015 Aug; 137:50-6.
-
Spectral-domain optical coherence tomography measurements of central foveal thickness before and after cataract surgery in children. J Cataract Refract Surg. 2015 Feb; 41(2):382-6.
-
Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology. 2014 Jan; 121(1):269-275.